Changes in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study
Clinics and Practice · 21.05.2026 · 16 (5) · 97
DOI: 10.3390/clinpract16050097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinics and Practice, online erschienen am 21.05.2026. Verfasst von Magdalena Lixandru und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is frequently accompanied by disturbances in coagulation and metabolic homeostasis, partly related to impaired handling of vitamin K-dependent pathways. Although vitamin K is often administered to correct abnormal coagulation tests, its biochemical impact in hospitalized patients with MASH remains insufficiently characterized. This study aimed to evaluate changes in coagulation and metabolic parameters in hospitalized patients with MASH receiving vitamin K supplementation.
Methods
We conducted a retrospective study of 84 hospitalized MASH patients who received vitamin K supplementation. Biochemical parameters were recorded at admission and discharge to assess short-term changes during hospitalization.
Results
Vitamin K supplementation was associated with modest changes in coagulation parameters, including reductions in PT, INR, and aPTT (e.g., PT decreased from 13.00 s to 11.00 s). Small numerical changes in transaminases, fasting glucose, and total cholesterol were observed during hospitalization, with limited clinical relevance. These patterns were comparable across fibrosis stages, with no significant differences between groups.
Discussion
The observed biochemical findings are likely in-hospital factors rather than a direct metabolic effect of vitamin K.
Conclusions
Vitamin K supplementation was associated with modest changes in coagulation parameters and small, clinically negligible variations in selected metabolic markers in patients with MASH, irrespective of fibrosis stage. These findings suggest a supportive biochemical effect in selected contexts; further prospective studies are needed to clarify their clinical relevance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania.
- Sibiu County Emergency Clinical Hospital, 550245 Sibiu, Romania.
- Valcea County Emergency Hospital, 240284 Valcea, Romania.
- Mathematics and Informatics Department, Research Center in Informatics and Information Technology, Faculty of Sciences, "Lucian Blaga" University of Sibiu, 550025 Sibiu, Romania.
ORCID-Profile: Magdalena Lixandru, George Maniu, Cosmin Ionut Lixandru
Zitieren
APA
Lixandru, M., Maniu, G., Lixandru, C. I., & Grosu, F. (2026). Changes in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study. Clinics and Practice, 16(5), 97. https://doi.org/10.3390/clinpract16050097
Vancouver
Lixandru M, Maniu G, Lixandru CI, Grosu F. Changes in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study. Clinics and Practice. 2026;16(5):97. doi:10.3390/clinpract16050097
BibTeX
@article{Lixandru2026,
author = {Lixandru, Magdalena and Maniu, George and Lixandru, Cosmin Ionut and Grosu, Florin},
title = {Changes in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study},
journal = {Clinics and Practice},
year = {2026},
volume = {16},
number = {5},
pages = {97},
doi = {10.3390/clinpract16050097}
}
EUVIMED